The Clinical Malaria (CM) Laboratory is a research group led by Associate Professor Bridget Barber within QIMR Berghofer Medical Research Institute in Brisbane, Australia.
CM aims to improve human health by contributing to the control of human parasitic diseases, particularly malaria. The main research themes of CM are:
- To evaluate the safety and activity of candidate antimalarial drugs and vaccines using the Induced Blood Stage Malaria (IBSM) model
- To investigate the biology of malaria parasites
- To investigate other parasitic tropical diseases, specifically scabies and helminth infections.
CM has developed an IBSM model to evaluate the safety and activity of candidate antimalarial drugs and vaccines. This model has shortened the time required to clinically evaluate candidate antimalarials. During 2017, CM extended the IBSM model to evaluate transmission-blocking interventions and antimalarial chemoprophylactic drugs, as well as developed master cell banks and systems to study artemisinin-resistant P. falciparum and for other Plasmodium species.
If you wish to apply for QIMR Berghofer's student program,
click here for more information.